Core Scientific (CORZ) FCF Margin (2021 - 2026)

Core Scientific has disclosed FCF Margin across 6 years of filings, most recently posting 120.92% for Q1 2026.

• FCF Margin for Q1 2026 came in at 120.92%, up 4132.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 129.98% (down 8053.0% YoY), and the FY2025 annual result was 141.29%, down 13110.0% from the prior year.
• FCF Margin came in at 120.92% for Q1 2026 at Core Scientific, up from 152.62% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 147.07% in Q4 2022 to a low of 162.24% in Q1 2025.
• The 5-year median for FCF Margin is 15.75% (2024), against an average of 38.71%.
• Across the five-year window, FCF Margin surged 17581 bps in 2022 and slumped 17456 bps in 2025, its largest moves.
• Core Scientific's FCF Margin stood at 147.07% in 2022, then plunged by 95 bps to 7.09% in 2023, then tumbled by 322 bps to 15.75% in 2024, then tumbled by 869 bps to 152.62% in 2025, then climbed by 21 bps to 120.92% in 2026.
• The last three FCF Margin figures came in at 120.92% (Q1 2026), 152.62% (Q4 2025), and 138.97% (Q3 2025), per Business Quant data.